Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-15 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −128,065 $52.97 $6.8M 548,556
2026-10-15 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −37,270 $54.20 $2.0M 511,286
2026-10-15 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −78,400 $55.02 $4.3M 432,886
2026-09-17 Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Sale 10b5-1 −8,282 $65.07 $539K 117,066
2026-09-17 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −101,691 $64.59 $6.6M 439,688
2026-09-17 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −6,802 $64.95 $442K 432,886
2026-09-16 Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Sale 10b5-1 −93,604 $63.25 $5.9M 196,179
2026-09-16 Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Sale 10b5-1 −79,113 $63.65 $5.0M 117,066
2026-09-16 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −99,716 $63.26 $6.3M 529,011
2026-09-16 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −96,125 $63.64 $6.1M 432,886
2026-09-16 ROTE WILLIAM E. Chief Research Officer Sale 10b5-1 −65,104 $63.12 $4.1M 145,943
2026-09-16 ROTE WILLIAM E. Chief Research Officer Sale 10b5-1 −47,746 $63.61 $3.0M 98,197
2026-09-15 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale 10b5-1 −27,473 $62.00 $1.7M 110,543
2026-09-15 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale 10b5-1 −20,735 $62.61 $1.3M 89,808
2026-09-15 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale 10b5-1 −1,900 $63.69 $121K 87,908
2026-09-15 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale 10b5-1 −400 $65.31 $26K 87,508
2026-09-15 Inrig Jula EVP, Head of R&D & CMO Sale 10b5-1 −25,390 $62.02 $1.6M 119,775
2026-09-15 Inrig Jula EVP, Head of R&D & CMO Sale 10b5-1 −17,284 $62.62 $1.1M 102,491
2026-09-15 Inrig Jula EVP, Head of R&D & CMO Sale 10b5-1 −1,600 $63.69 $102K 100,891
2026-09-15 Inrig Jula EVP, Head of R&D & CMO Sale 10b5-1 −400 $65.31 $26K 100,491

Page 1 of 22 · 429 trades